Cost Minimization of Medicare Part D Prescription Drug Plan Expenditures

被引:0
|
作者
Patel, Rajul A. [1 ]
Lipton, Helene Levens [2 ]
Cutler, Timothy W. [2 ]
Smith, Amanda R. [2 ]
Tsunoda, Shirley M. [3 ]
Stebbins, Marilyn R. [2 ]
机构
[1] Univ Pacific, Dept Pharm Practice, Stockton, CA 95211 USA
[2] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA
来源
AMERICAN JOURNAL OF MANAGED CARE | 2009年 / 15卷 / 08期
关键词
TRIAL;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: To minimize out-of-pocket prescription drug plan (PDP) expenditures by Medicare beneficiaries. Study Design: Cost-minimization analysis. Methods: Trained student pharmacists from 6 California pharmacy schools provided expert guidance on Medicare Part D PDPs to beneficiaries through interventions at statewide outreach events. Demographic and insurance information for 2008 was collected via survey. Cost information for the beneficiary's current PDP for 2008 and for the least expensive PDP for 2008 was obtained using the Medicare Plan Finder tool (http://www.medicare.gov). Results: Data were collected from 250 beneficiaries at 22 outreach events. For the cost-minimization analysis, data were excluded from 72 beneficiaries who were not enrolled in a stand-alone PDP before the intervention and from another 23 beneficiaries for whom information regarding their current PDP or prescription drug profile was incomplete. Of the remaining 155 study participants, 39.4% were male, the mean (SD) age was 74.6 (8.7) years, and they were taking a mean (SD) of 5.3 (3.5) prescription drugs each month. In addition, 68 beneficiaries (43.9%) had limited or no English proficiency, and 85 beneficiaries (54.8%) were enrolled in both Medicare and Medicaid. In total, 89.7% of beneficiaries could have realized cost savings by switching to a different PDP. The median annual potential cost savings was $98 per beneficiary but this varied as a function of subsidy level. Conclusion: Targeted community outreach services to Medicare Part D beneficiaries can help optimize patient selection of a PDP, thereby resulting in lower out-of-pocket expenditures. (Am J Manag Care. 2009; 15(8):545-553)
引用
收藏
页码:545 / 553
页数:9
相关论文
共 50 条
  • [1] Student pharmacist interventions lead to cost minimization of medicare part D prescription drug plan costs
    Lipton, H. L.
    Patel, R. A.
    Smith, A. R.
    Cutler, T. W.
    Stebbins, M. R.
    VALUE IN HEALTH, 2008, 11 (03) : A249 - A250
  • [2] The effect of the medicare Part D prescription benefit on drug utilization and expenditures
    Yin, Wesley
    Basu, Anirban
    Zhang, James X.
    Rabbani, Atonu
    Meltzer, David O.
    Alexander, G. Caleb
    ANNALS OF INTERNAL MEDICINE, 2008, 148 (03) : 169 - 177
  • [3] Patient Experiences in Selecting a Medicare Part D Prescription Drug Plan
    Stults, Cheryl D.
    Baskin, Alison S.
    Bundorf, M. Kate
    Tai-Seale, Ming
    JOURNAL OF PATIENT EXPERIENCE, 2018, 5 (02): : 147 - 152
  • [4] The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures
    Yin, W.
    Basu, A.
    Zhang, J.
    Rabbani, A.
    Meltzer, D.
    Alexander, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 620 - 620
  • [5] Will Part D produce savings in Part A and Part B? The impact of prescription drug coverage on Medicare program expenditures
    Stuart, Bruce C.
    Briesacher, Becky A.
    Doshi, Jalpa A.
    Wrobel, Marian V.
    Baysac, Fatima
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2007, 44 (02) : 146 - 156
  • [6] The Medicare Part D Coverage Gap, Prescription Use, and Expenditures
    Unuigbe, Aig
    MEDICAL CARE RESEARCH AND REVIEW, 2020, 77 (05) : 442 - 450
  • [7] THE IMPACT OF MEDICARE PART D DRUG COVERAGE ON TOTAL PRESCRIPTION DRUG EXPENDITURES AMONG CANCER PATIENTS IN 2014
    Ma, S.
    VALUE IN HEALTH, 2018, 21 : S46 - S46
  • [8] Potential opportunity cost of neglecting to annually reassess Medicare Part D standalone prescription drug plan offerings: The price of contentment?
    Walberg, Mark P.
    Patel, Rajul A.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2009, 49 (06) : 777 - 782
  • [9] The cost of choice in the medicare prescription plan
    Hayes, J.
    Prochazka, A. V.
    Pistone, B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 : 139 - 139
  • [10] Predictability of prescription drug expenditures for Medicare beneficiaries
    Wrobel, MV
    Doshi, J
    Stuart, BC
    Briesacher, B
    HEALTH CARE FINANCING REVIEW, 2003, 25 (02): : 37 - 46